GENNEX

The stock has been placed in Additional Surveillance Measure (ASM) list STASM - I.

Gennex Laboratories Ltd.

BSE: 531739

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

12.18+0.0 (+0.25%)

26 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

13.0 / 100

Value Score

70.1 / 100

Price Momentum Score

33.3 / 100

QVM Score

24.7 / 100

Key Metrics

Market Cap

277.03

P/E (TTM)

14.84

P/B

1.24

P/S (TTM)

1.55

EV/EBITDA

7.16

CAPE (5Y)

20.34

ROE (TTM)

9.02

ROCE (TTM)

7.87

ROA (TTM)

6.10

Avg 3Y ROE

9.89

Earnings 3Y CAGR

23.13

Sales 3Y CAGR

37.82

Sales 5Y CAGR

25.64

Debt/Equity

0.16

Consensus TP

Strong Buy %

Promoter Holding

23.63

Pledged %

21.77

Stock Analysis

Fundamental analysis overview of Gennex Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 14.84 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -51.42%

What is P/E Ratio?

Median: 30.55

Value 14.84

-0.99726.77

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 24.1% for 12-month ended 30 Jun 2026 and the growth was 13.51 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 24.1

-99.6111701.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.16 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.03 in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low but stable ROE

The company reported low ROE of 9.02% for 12-month ended 30 Jun 2026 and ROE declined marginally by -112 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -2.23% for 12-month ended 30 Jun 2026 and the growth was 9.43 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Company's earnings are of low quality

Earnings quality score of 5.1 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

5.1 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Moderate and stable operating margin

The company reported moderate operating margin of 10.33% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 7 bps from 1 year ago

What is Operating profit margin?

Financial Snapshot

See detailed analysis

Multi-year trends for Gennex Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Gennex Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Gennex Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	22.05	22.05	22.05	22.05	22.05	22.05	22.05	22.05	22.05	22.05	23.38	23.38	23.38	23.38	23.60	23.60	18.42	18.42	18.42	18.42	18.42	19.83	23.62	23.62	23.63	23.63
Indian Promoter	22.05	22.05	22.05	22.05	22.05	22.05	22.05	22.05	22.05	22.05	23.38	23.38	23.38	23.38	23.60	23.60	18.42	18.42	18.42	18.42	18.42	19.83	23.62	23.62	23.63	23.63
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	77.95	77.95	77.95	77.95	77.95	77.95	77.95	77.95	77.95	77.95	76.62	76.62	76.62	76.62	76.39	76.39	81.58	81.58	81.58	81.58	81.58	80.17	76.38	76.38	76.37	76.37
Bodies Corporate	16.81	17.89	18.06	18.15	12.81	5.90	1.90	2.82	1.50	2.20	11.49	11.81	12.42	14.95	16.78	13.33	15.48	14.42	15.56	13.97	12.67	11.42	10.52	13.97	15.07	14.30
Others (incl. Retail) No. of shareholders	61.14 12,985	60.06 17,981	59.89 18,046	59.80 18,685	65.14 20,685	72.05 35,934	76.05 46,258	75.13 49,846	76.45 56,557	75.75 57,752	65.13 59,036	64.81 58,131	64.20 55,507	61.67 52,892	59.61 50,890	63.06 69,569	66.10 83,818	67.16 87,631	66.02 89,958	67.61 92,212	68.91 92,051	68.75 90,923	65.86 90,057	62.41 86,051	61.30 83,890	62.07 82,644

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Gennex Laboratories Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Premier Fiscal Services Pvt Ltd Promoter	September-2023	Market (Acquisition) 27th Sep 2023	21.14 %	₹ 7.67	9.00 k	₹ 69.01 k
Premier Fiscal Services Pvt Ltd Promoter	September-2023	Market (Acquisition) 16th Sep 2023	21.13 %	₹ 7.90	29.00 k	₹ 2.29 lac

Corporate Actions

History of Gennex Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Rights Issue(1 new shares @ ₹6 for 2 existing shares)
Ex-date: 21st Jul 2022Announced on: 16th Jul 2022
Stock Split1 : 10
Ex-date: 14th Dec 2009Announced on: 10th Sep 2009
EGM 31 October 2009. Nominal value change from Rs 10 to Rs 1.

Company Profile

Overview of Gennex Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal m...

Key personnel

Shri. K. V. L. N. Bhaswanth

Chief Operating Officer, Compliance Officer

Shri. Arihant BaidD

Managing Director, Director

Shri. Tiruvarur Muralidharan GopalakrishnanD

Whole Time Director

Shri. U. C. BhandariD

Non-Executive Independent Director

Mr. Yellu Ravinder ReddyD

Non-Executive Independent Director

Incorporated on

29 Mar 1990

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

09 Feb 1996

Free Float

15,43,26,222

Website

https://www.gennexlab.com/

Phone no.

+914067334400

Address

133,BOLLARAM JINNARAM MEDAK, , 502325, India

Frequently Asked Questions

What is the current share price of Gennex Laboratories Ltd.?

The current share price of Gennex Laboratories Ltd. is ₹ 12.18 as of 26 Aug 2026.

What is the market capitalisation of Gennex Laboratories Ltd.?

The market capitalisation of Gennex Laboratories Ltd. stands at ₹ 277.03 Cr.

What is the PE ratio of Gennex Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Gennex Laboratories Ltd. is 14.84 as of the latest trailing twelve months data.

What is the ROE and ROCE of Gennex Laboratories Ltd.?

Gennex Laboratories Ltd. has a Return on Equity (ROE) of 9.02% and a Return on Capital Employed (ROCE) of 7.87% as per the latest financial reports.

What is the 52-week high and low of Gennex Laboratories Ltd.?

The 52-week high of Gennex Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Gennex Laboratories Ltd.?

The dividend yield of Gennex Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Gennex Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 62.07% of Gennex Laboratories Ltd. shares.

What sector does Gennex Laboratories Ltd. belong to?

Gennex Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Gennex Laboratories Ltd.?

The beta of Gennex Laboratories Ltd. is 1.34, indicating its price volatility relative to the broader market. Over the past 1 year, Gennex Laboratories Ltd. has delivered an absolute return of -1.62%.

What is the RSI of Gennex Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Gennex Laboratories Ltd. is 70.42, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Gennex Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Gennex Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile